Literature DB >> 362292

[Progress in the therapy of medulloblastoma].

M Wannenmacher, H Knüfermann.   

Abstract

The nearly exclusive metastatic spread of the radiosensitive medulloblastoma into the fluid spaces of the liquor system allows a curative therapeutic attempt by a systemic radiation. The actual 5-years survival rate is about 40%. It should be possible to improve it to up to 50% by consequently applicating radiotherapy. A prospective study concerning the possibilities of chemotherapy presently underway, does not yet permit a definite statement. The most essential complication after radiotherapy of children concerns the symmetric reduction of growth.

Entities:  

Mesh:

Year:  1978        PMID: 362292     DOI: 10.1159/000213926

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  1 in total

1.  Intra-arterial BCNU in the treatment of recurrent medulloblastoma.

Authors:  K Watne; B Hager; H Hirschberg
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.